WHO ICTRP trial
COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in…
EUCTR2020-001244-26-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2020-001244-26-AT |
|---|---|
| Public title | COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial. |
| Scientific title | COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial. |
| Primary sponsor | Department of Clinical Pharmacology, Medical University of Vienna, Vienna Austria |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Austria |
| Conditions | Pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS MedDRA version: 21.1 Level: LLT Classification code 10003083 Term: ARDS System Organ Class: 10038738 - Respiratory, thoracic and mediastinal… |
| Interventions | Product Name: Solnatide Pharmaceutical Form: Powder for nebuliser suspension INN or Proposed INN: Solnatide CAS Number: 259206-53-06 Current Sponsor code: AP301 Other descriptive name: human tumour necrosis factor alpha-derived peptide… |
| Registration date | Mar 31, 2020 |
| Target size | 40 |
| Secondary IDs | COV-2-SOLNATIDE-20 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: